FDA Inspection
Los Angeles Reproductive CenterLos Angeles Reproductive Center – FDA Inspection, Dec 12, 2023
Record Details
This FDA Inspection record concerns Los Angeles Reproductive Center, with an inspection on December 12, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · f289edfe-565a-4161-9656-1480a6dc60cb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224904
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 1271.75(d)Donors with risks not determined ineligible
- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.75(d)Donors with risks not determined ineligible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Los Angeles Reproductive Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Los Angeles Reproductive Center
- FDA Inspection 1072891 - 2018-10-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.